Search Results - "Tiendrébeogo, Sylvestre"
-
1
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
Published in The Lancet infectious diseases (01-10-2012)“…Summary Background An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in…”
Get full text
Journal Article -
2
Sexual and Reproductive Life of Women Informed of Their HIV Seropositivity: A Prospective Cohort Study in Burkina Faso
Published in Journal of acquired immune deficiency syndromes (1999) (01-12-2001)“…BACKGROUND:In the context of the DITRAME-ANRS 049 research program that evaluated interventions aimed at reducing mother-to-child transmission of HIV (MTCT) in…”
Get full text
Journal Article -
3
Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
Published in Clinical infectious diseases (01-02-2013)“…Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of…”
Get full text
Journal Article -
4
Meningitis serogroup W135 outbreak, Burkina Faso, 2002
Published in Emerging infectious diseases (01-06-2007)“…In 2002, the largest epidemic of Neisseria meningitidis serogroup W135 occurred in Burkina Faso. The highest attack rate was in children <5 years of age. We…”
Get full text
Journal Article -
5
Bacterial Meningitis in Burkina Faso: Surveillance Using Field-Based Polymerase Chain Reaction Testing
Published in Clinical infectious diseases (01-01-2005)“…Background. In addition to frequent epidemics of group A meningococcal disease, endemic bacterial meningitis due mostly to Neisseria meningitidis,…”
Get full text
Journal Article -
6
Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003
Published in Vaccine (03-09-2007)“…Abstract Following a large Neisseria meningitidis W135 (NmW135) epidemic in Burkina Faso (BF) during 2002, a newly licensed trivalent A/C/W135 meningococcal…”
Get full text
Journal Article -
7
Predictors of Immunity after a Major Serogroup W-135 Meningococcal Disease Epidemic, Burkina Faso, 2002
Published in The Journal of infectious diseases (01-03-2006)“…BackgroundThe African meningitis belt undergoes recurrent epidemics caused by Neisseria meningitidis serogroup A. During 2002, Burkina Faso documented the…”
Get full text
Journal Article -
8
Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso
Published in Vaccine (03-09-2007)“…Abstract During a mass campaign with a newly licensed meningococcal polysaccharide ACW135 vaccine in Burkina Faso, adverse events following immunization (AEFI)…”
Get full text
Journal Article -
9
Measles Incidence Before and After Mass Vaccination Campaigns in Burkina Faso
Published in The Journal of infectious diseases (15-05-2003)“…Burkina Faso conducted mass measles vaccination campaigns among children aged 9 months to 4 years during December 1998 and December 1999. The 1998 campaign was…”
Get full text
Journal Article -
10
Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin
Published in Vaccine (14-03-2014)“…Highlights • The first field use of MenAfriVac's new label allowed the vaccine to be kept at up to 40 °C for up to 4 days. • 155,000 people were vaccinated…”
Get full text
Journal Article -
11
Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
Published in Vaccine (30-05-2012)“…Highlights ► Introduction of a new meningitis vaccine in Burkina Faso in 2010 was a huge success. ► More than 11 million Burkinabe (100% target population)…”
Get full text
Journal Article -
12
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt
Published in Vaccine (01-03-2013)“…Abstract For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in areas of the African Sahel and sub-Sahel known as the…”
Get full text
Journal Article Conference Proceeding -
13
-
14
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15
Published in Clinical microbiology and infection (01-12-2018)“…Antimicrobial resistance (AMR) is a priority for surveillance in bacterial infections. For leprosy, AMR has not been assessed because Mycobacterium leprae does…”
Get full text
Journal Article -
15
-
16
Stabilization of HIV infection rates in urban Burkina Faso, 1995-1999
Published in International journal of STD & AIDS (01-07-2001)“…The objectives of this study were to monitor the trends of the HIV epidemic between 1995 and 1999 among pregnant women in Bobo-Dioulasso, the second largest…”
Get more information
Journal Article -
17
Infection maternelle par le VIH et paramètres anthropométriques de l'enfant à la naissance au Burkina Faso
Published in Santé (Montrouge, France) (01-05-1999)Get full text
Journal Article